Post My Press Release

Free Press Release Distribution

Category: Hardware (Page 1 of 2)

Digital Utility Market Value to reach $244.31 Billion by 2022

According to the new market research report Digital Utility Market by Network (Generation, Transmission and Distribution, and Retail), Technology (Hardware and Integrated Solutions (Cloud and Software, Services)), and Region (North America, Europe, and Asia-Pacific) – Global Forecast to 2022″, published by MarketsandMarkets™, Global digital utility market is projected to grow at a CAGR of 12.57%, from 2017 to 2022, to reach a market size of USD 244.31 billion by 2022. North American market held the largest share in 2016 followed by the markets in Europe and Asia-Pacific. However, by 2022, the market in Asia-Pacific is projected to gain the largest share. Digital utility market growth is driven by strict regulatory requirements for electric utilities, energy efficiency mandates demanding carbon emission reduction, and increase in the number of distributed and renewable power generation projects.

Don’t miss out on business opportunities in Digital Utility Market. Speak to Analyst and gain crucial industry insights that will help your business grow:

https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=230978516

The digital utility market in Asia-Pacific is projected to grow at the fastest rate during the forecast period. Increasing investment in the electrical infrastructure and growing decentralized power generation will be driving the growth of the digital utility market in the region during the forecast period. The developing smart grid projects and investments in smart cities are also driving the digital utility market in Asia-Pacific.

Browse and in-depth TOC on “Digital Utility Market

63 – Tables

35 – Figures

144 – Pages

View more detailed TOC @

https://www.marketsandmarkets.com/Market-Reports/digital-utility-market-230978516.html

The growth of the transmission and distribution segment is primarily driven by aging infrastructure in the power utilities industry. New digital devices and communications and control systems improve the efficiency of assets and increase the ability of operators to monitor and manage electric transmission and distribution systems. This would ultimately create new revenue pockets for the digital utility market during the forecast period.

North America: The largest market for digital utility

The market in North America is currently the largest market for digital utility, closely followed by the European market. Rising investments in aging electrical infrastructure and increasing electricity demand are driving the digital utility market in the North America. The market in the U.S. is estimated to be the largest in the region, followed by the markets in Canada and Mexico, during the forecast period.

Download PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=230978516   

The leading players in the digital utility market includes Accenture plc (Ireland), Cap Gemini S.A. (France), Cognizant Technology Solutions Corporation (U.S.), General Electric Company (U.S.), Siemens AG (Germany), SAP SE (Germany), International Business Machines Corporation (U.S.), and Oracle Corporation (U.S.), among others.

About MarketsandMarkets™

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the “Growth Engagement Model – GEM”. The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write “Attack, avoid and defend” strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets’s flagship competitive intelligence and market research platform, “Knowledge Store” connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.


Contact:

Mr. Shelly Singh

MarketsandMarkets™ INC.
630 Dundee Road

Suite 430

Northbrook, IL 60062

USA : 1-888-600-6441

Email: sales@marketsandmarkets.com

Radiation-Induced Myelosuppression Treatment Market By 2028 Region, Application, Driver, Trends & Forecasts

radiation induced myelosuppression treatment market

Rapidly improving healthcare infrastructure and reimbursement scenario has been a major booster for the healthcare industry in developing regional markets. With incessantly increasing number of cancer cases, it is more likely that the subsequent demand for a wide range of treatments adopted to treat cancer patients would also remain on a constant rise over the course of coming years.

Radiation therapy has been a significant part of cancer treatment and the consistently high success rate associated with radiotherapy is projected to further push demand for radiation-induced myelosuppression treatment worldwide.

A new market research study on global radiation-induced myelosuppression treatment forecasts steady growth for the market in the next few years. Future Market Insights projects a moderate, just-under 4% yearly growth outlook, in 2019 and ahead.

Nutropenia is foreseen to generate maximum demand for radiation-induced myelosuppression treatment, whereas injectables are identified to hold a substantial share in the total market value, based on the route of administration of radiation-induced myelosuppression treatment. Thrombocytopenia and anemia are likely to present lucrative opporunities for radiation-induced myelosuppression treatment providers.

Request Sample Report @ https://www.futuremarketinsights.com/reports/sample/rep-gb-8116 

Report tracks key factors driving revenue growth of the market –

  • Increasing prevalence of cancers
  • Early diagnosis, promising improved chances of positive outcomes
  • Fostering R&D funds supporting cancer research
  • Strong product pipeline
  • Bolstering adoption of chemo-radiotherapy in cancer treatment

In the backdrop of patent expiry, a majority of market leaders are shifting their focus to the expansion of product pipeline of a wide range of innovative formulations, likely to shape the radiation-induced myelosuppression treatment landscape.

  • Myelo001 by Myelo Therapeutics GmbH recently received an FDA approval as an orphan drug to be used in the ARS (acute radiation syndrome) treatment.
  • Mylan NV and Pfizer Inc. also reveived FDA approvals for their recently launched biosimilars – Epogen and Neupogen, and Neulasta respectively.

Patent expiry of originator biologics formulations is creating investment opportunities in biosimilars production – for the operators in radiation-induced myelosuppression treatment landscape. As there is a considerable cost difference of around 20% between originator biologics and biosimilars, patients are inclined more towards an economical means of treatment, thereby fueling the scope of penetration of radiation-induced myelosuppression treatment in coming years.

Backed by a majority of established players housing strong bases across North America, especially the US, the report indicates a steady growth outlook for the radiation-induced myelosuppression treatment market in the region. North America will reportedly continue to account for over 65% share in the global market value.

New product launches currently mark the top developmental strategy adopted by leading companies competing in the radiation-induced myelosuppression treatment market. A majority of key players are also identified to focus on enhancing their geographical foothold in global radiation-induced myelosuppression treatment landscape.  The report in a distinct section covers some of the key competitors operating in radiation-induced myelosuppression treatment marketplace, emphasizing their financial as well as strategic profiles in depth.

Request to View TOC @ https://www.futuremarketinsights.com/askus/rep-gb-8116

A few of the profiled companies include Pfizer Inc., Janssen Pharmaceutical NV, Janssen Global Services, LLC (Johnson & Johnson), Amgen Inc., Mylan NV, Teva Pharmaceutical Industries Ltd., Novartis AG, and Partner Therapeutics, Inc.

In the highly consolidated competitive landscape of global radiation-induced myelosuppression treatment, the three top ranking companies, i.e. Janssen Pharmaceutical NV, Amgen Inc., and Teva Pharmaceutical Industries Ltd. dominate in terms of market value. These players continue to hold winning revenue shares in the radiation-induced myelosuppression treatment owing to strong global presence and a considerable number of new drug approvals. Established companies are entering strategic partnerships and collaborations with regional leaders, in an effort to achieve better penetration into regional markets.

Population Health Management Solution Market To Be At Forefront By 2026

Coherent Market Insights added Latest Research Report titled ” Population Health Management Solution Market, by Component (Software and Services), by Medium (Web Based Medium, and Cloud Based Medium), by End User (Hospitals, Ambulatory Care Provider, Insurance Provider, and Others), and by Region – Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2018-2026 ” to its Large Report database.

Population health management solution aggregates all the data from different healthcare platform (Diagnostics, Pharmacy, and Billing Department in healthcare facility) related to the patient. The data is analyzed and presented in comprehensive actionable form to healthcare providers for efficient clinical outcome and save overall healthcare cost. Population healthcare management tracks individuals amongst vast group of patients by applying business intelligence tools to different set of data and create single document, which is easy to analyze and clinical decision can be taken over same by each member across the healthcare ecosystem.

Population healthcare management provides various advantages. It improves quality of healthcare due to comprehensive picture provided by collection of multiple data points on one platform with better tracking of patient. Pharmaceutical healthcare management solutions saves unnecessary healthcare cost. Also, it allows better clinical management in case of chronic disease using information technology based approaches. Healthcare management allows the healthcare provider to fill the healthcare gap i.e. lack of coordinated effort amongst stakeholder in health care, lack of effective patient monitoring etc.

This is gap can be filled by promoting real time data access and monitoring. This can be done by monitoring diagnostic data, prescription data, billing data and other health care data, which can be assessed and addressed in case of care gap. For healthcare insurer, population healthcare management allows the value-based reimbursement rather than simple payment transfer and helps in business decision making process. Overall PHM promotes better health for population and reduces hospital admissions.

Market Dynamics

Population healthcare management market is projected to witness upward growth during the forecast period due to increasing prevalence of chronic disease worldwide. Chronic disease such as cancer, cardiovascular disease, diabetes, asthma (chronic lung disease) account for the major healthcare burden annually. According to World Health Organization data in 2017, around 40 million people die each year due to chronic disease, which accounts for 70% of all deaths globally. Cardiovascular diseases is responsible for 17.7 million death annually, followed by cancers (8.8 million deaths), respiratory diseases (3.9million deaths), and diabetes (1.6 million deaths).

Population healthcare management solutions provides better clinical management of this disease. Increasing number of geriatric population worldwide is expected to further propel growth of population healthcare management solutions.

Competitive Landscape

Some of the key players operating in the population health management solution market include Allscripts, Inc., Cerner Corporation, Conifer Health Solutions, Healthagen, LLC, OptumHealth, Epic Corporation, Inc., Philips Wellcentive, eClinicalWorks, Health Catalyst, LLC, IBM Corporation, i2i Population Health, Verscend Technologies, Inc., Caradigm, and Care Evolution.

Ask For Sample Copy Of This Business Research Report : https://www.coherentmarketinsights.com/insight/request-sample/1732

Market Taxonomy

On the basis of component, the global population health management solution market is segmented into:

  • Software
  • Services

On the basis of medium, the global population health management solution market is segmented into:

  • Web based medium
  • Cloud based medium

On the basis of end user, the global population health management solution market is segmented into:

  • Hospitals
  • Insurance provider
  • Ambulatory care provider
  • Others

Regional Insights

Reducing number of uninsured people would also benefit the market. According to U.S. Census Bureau data, in 2016, an estimated 8.8 percent or 28.1 million people were without health insurance coverage, which is lower than 2015, in which 9.1 percent or 29.0 million people were uninsured. Europe is projected to be second lucrative market due to high number of old age population. According to Europa Statistics in 2017, around 19% of current Europe population is more than 60 in age, which would rise to 25% in near future.

Asia Pacific region provides potential opportunity for growth of the population health management solution market, owing to highest number of deaths caused due to chronic disease. More than 12 million and around 80% worldwide chronic disease death are reported from this region according to World Health Organization (WHO) factsheet in 2017. Healthcare infrastructure in this region is slowly improving, which would also promote use of population health management solution.

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:

Mr. Shah
Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: sales@coherentmarketinsights.com

Spinal Stenosis Market Industry Outlook, Size, Share, Growth Prospects, Key Opportunities, Trends and Forecasts 2016-2026

Spinal stenosis is narrowing of the spinal column and mainly occurs from a combination of aging and degenerative changes in the spine. This puts pressure on the spinal cord and the spinal nerve roots, and may cause pain, numbness, or weakness in the legs. Spinal stenosis mostly affects people above 60 years of age but can also occur in younger people born with the abnormal spinal canal. Lumbar spinal stenosis, cervical spinal stenosis and thoracic spinal stenosis are the three main types of spinal stenosis. About 75% of the cases of spinal stenosis occurs in the lower lumbar region.

The primary symptoms associated with spinal stenosis are radiculopathy and myelopathy. Myelopathy is of greater concern as pressure on the spinal cord can lead to permanent spinal cord damage.  Diagnosis of spinal stenosis involves the complete evaluation of spine. The most common diagnostic test for spinal stenosis are MRI scan and X-ray. In some cases CT scan can be conducted in order to diagnose the condition. Spinal stenosis treatment can be conservative or surgical depending upon the severity of the disease.

Spinal Stenosis Market: Drivers and Restraints

Increasing prevalence of degenerative spondylolisthesis and degenerative scoliosis among rapidly ageing population, rising number of obese population suffering from spine deformities, and rising demand for minimally invasive spine surgery procedures are the key factors fueling the growth of the global spinal stenosis market. However, high cost of treatment procedure, stringent product approval process and unclear reimbursement policies are the prime factors expected to hamper the global spinal stenosis market growth.

Spinal Stenosis Market: Segmentation

The global spinal stenosis market is segmented based on product type, treatment type end user and region.

Based on Product Type

  • Thoracic Fusion and Lumbar Fusion Devices
    • Anterior Thoracic and Lumbar Fusion Devices
    • Posterior Thoracic and Lumbar Fusion Devices
    • Interbody Thoracic and Lumbar Fusion Devices
  • Cervical Fusion Devices
    • Anterior Cervical Fusion Devices
    • Posterior Cervical Fusion Devices

Request Sample Report @  https://www.futuremarketinsights.com/reports/sample/rep-gb-1388 

Based on treatment type

  • Surgical treatment
    • Discectomy
    • Laminectomy
    • Foraminotomy
    • Facetectomy
    • Corpectomy
  • Non-Surgical Treatment

Based on end user type

  • Hospitals
  • Ambulatory Surgical centers
  • Rehabilitation Centers

Spinal Stenosis Market: MarketOverview

Numerous prescription medications are available to cure spinal stenosis. Epidural steroid injections and anti-inflammatory medications may be used to in case of acute spinal stenosis. Such nonsurgical treatments offer ways to control symptoms and enable you to improve without surgery. Whereas patients with chronic spinal stenosis opt for surgical procedures such as laminectomy, corpectomy foraminotomy and others.  Due to rapidly ageing population and increasing prevalence of osteoarthritis, rheumatoid arthritis and spondylolisthesisare expected fuel the market value of global Spinal Stenosis market over the forecasted period.

Spinal Stenosis Market: Region-wise Overlook

Geographically, North America is expected to dominate the global spinal stenosis market followed by Europe owing to increase in number of aging population. This increase in the base of geriatric population is expected to result in rising prevalence of spinal disorders such as herniated discs and osteoarthritis. In addition, ready availability of skilled healthcare professionals would significantly lead to increase in number of surgical procedures thereby driver the growth of spinal stenosis market during the forecast period. However, lack of adequate physician and patient awareness/education about newly developed treatment procedures and technologies and high pricing pressure on market players are other factors hampering market growth. Asia-Pacific is expected to exhibit strongest growth dynamics in spinal stenosis market due to rising economic affluence in various parts of this region.

Request to View TOC @  https://www.futuremarketinsights.com/toc/rep-gb-1388

Spinal Stenosis Market: Key Players 

Key companies operational in global spinal stenosis market are Medtronic Inc., DePuy Synthes, Stryker Corporation, Orthofix International N.V., NuVasive, Inc., Zimmer Biomet Holdings, Inc., Globus Medical, Inc., Alphatec Holdings, Inc., K2M Group Holdings, Inc., and LDR Holding Corporation.

Endoscopy Visualization System Market Industry Outlook, Size, Share, Growth Prospects, Key Opportunities, Trends and Forecasts 2018 – 2028

Around 3/4th share of the total revenue of endoscopy visualization systems landscape is accounted by Tier 1 players that are prominently focusing on cost effective product development

  • Leaders in endoscopy visualization systems landscape are also prioritizing innovative product launches, product portfolio extension, and strategic collaborations and mergers for an even stronger market footprint.
  • Tier 2 and Tier 3 companies, making up for the rest of market revenue, are particularly focusing on regional expansion – especially targeting developing Asian economies.

Prominently due to the paradigm shift to value based, sophisticated healthcare system and a mounting number of strategic mergers and acquisitions between leading medical device manufacturers, endoscopy visualization systems have been witnessing robust demand in recent years.

“With an ever growing demand for minimally invasive surgical procedures and growing availability of low-cost diagnostic procedures, we expect robust expansion of the global revenue through endoscopy visualization systems. While endoscopy visualization systems currently account for a billion dollar market globally, it is more likely that the endoscopy visualization systems landscape will observe over 7% year on year growth in 2019. Relatively undemanding FDA clearance guidelines is another strong factor pushing the prospects for endoscopy visualization systems in the near future,” says a senior research analyst at Future Market Insights.

Request Sample Report @  https://www.futuremarketinsights.com/reports/sample/rep-gb-7596 

Innovation of Endoscopy Visualization Systems Takes a Grand Leap beyond 3D Imaging

The 3D endoscope visualization system has been an impactful innovation in the endoscope visualization systems landscape. While 3D visualization technology offers a deeper view of the diagnostic area during endoscopic procedures, constant R&D efforts have directed the innovations to the latest – customized 3D visualization. The world’s first-ever endoscopy visualization system (by MedicalTek) has been recently launched that works on an easy-to-set and easy-to-alter imaging technique and offers an adjustable 3D perception to resultant endoscopic images.

Product Type Assessment: Adapting to the Trend of Minimally Invasive Surgery Demand, High-range Endoscopy Visualization Systems Remain the Top Seller

The FMI analyst explains that ever-growing demand for minimally invasive surgical procedures worldwide, it is quite clear that high-range endoscopy visualization systems will continue to bring in maximum revenue to the marketplace. With a current market value share of around 50%, high-range endoscopy visualization systems will be the highest selling type of EVS owing to favorable reimbursement policies and availability of advanced technology systems in this segment. Mid-range endoscopy visualization systems are also identified to capture a considerable market value share in 2019, demonstrating the year-on-year expansion of over 7%.

Diagnostic Area-wise Analysis: Maximum Opportunities Exist for GI Tract Endoscopy Visualization Systems

Recent statistical data published by American Society of Gastrointestinal Endoscopy (ASGE) indicates that among roughly 75 million endoscopic procedures annually performed at a global level, more than 65% are performed on the gastrointestinal tract, followed by the female reproductive tract. A considerable number of endoscopies are also performed through a small-sized incision with an objective to achieve least invasion. According to FMI’s projection for 2019, the year on year revenue growth will be around 7% in case of gastrointestinal tract endoscopy visualization systems, whereas that in case of small-sized incision procedures will be more than 7%.

Regional Outlook: Asia Pacific Becomes an Attractive Growth Platform for Manufacturers of Endoscopy Visualization Systems

While developing economies are constructing a lucrative base for the growth of endoscopy visualization systems landscape through changing demographics and an expanding patient pool, Future Market Insights offers exclusive insights on the same. An elevating number of endoscopy visualization systems predominantly for disorders of GI tract, female reproductive system, urinary tract, and respiratory system is encouraging the sales of endoscopy visualization systems in emerging Asian economies.

Request to View TOC @  https://www.futuremarketinsights.com/askus/rep-gb-7596

The FMI analyst says while unfolding the key attributes driving expansion of market within emerging regional territories, “While APEJ is at present the second largest market for endoscopy visualization systems after North America, Japan is also witnessing significant growth. This growth can be attributed to both, a healthy rate adoption of endoscopy visualization systems at hospitals, and impressively growing sales at specialty clinics”.

Laboratory Accessories Market Size, Share,Outlook, and Opportunity Analysis, 2018 – 2026

Laboratory (lab) accessories refer to the tools used for conducting scientific research or experiments, and may also be used for teaching practical science. Lab accessories play a very crucial role in laboratories to provide reliable, accurate, and expeditious outcomes. Lab accessories are portable and are used in hospitals, clinics, diagnostic centers, and pathological centers among others. Laboratory accessories include laboratory instruments, general lab equipment, glassware, consumables, and other accessories.


Download PDF Brochure of This Business Research Report :
https://www.coherentmarketinsights.com/insight/request-pdf/2035

In 2014, National Science Foundation’s (NSF) annual Business Research and Development and Innovation Survey (BRDIS) data tracked the research activities of 46,000 companies. According to their survey, the drug companies have increased their investment on research & development from US$ 3 billion in 2008 to US$ 8.1 billion in 2014. NSF also stated that there is slow, however, steady rise in spending of basic research by universities and private foundations. These factors are expected to boost the global laboratory accessories market growth over the forecast period.


Global Laboratory Accessories Market Drivers
:-

Continuous laboratory product launches due to increasing demand for laboratory accessories is expected to support the global laboratory accessories market growth over the forecast period. There is a constant increase in demand for laboratory accessories, due to growing competition in pharmaceutical and diagnostic industries (as lab accessories are basic requirements to run a laboratory). In order to meet the ever growing demand for lab accessories, manufacturers have to keep on introducing newer products with advanced technology to support the lab automation.

For instance, along with conventional lab accessories, products such as microplates and modular lab tables are also gaining popularity. Technological advancement aimed at improving utility and ease of handling is expected to support growth of global laboratory accessories market over the forecast period. Products offered by manufacturers such as Thermo Fisher Scientific include Dimension 4 Modular Lab Tables, Microplate Carousel, Plate Feeder Carousel, and Microplate Delidders. Dimension 4 Modular Lab Tables provide a highly scalable, flexible, and a stable platform for lab systems and work stations. Micro Plate Carousel provides access to 104 deep well microplates and 200 microplates. Microplate Delidders automates the storage, replacement of lids and storage of microplates.


Global Laboratory Accessories Market Regional Insights:-

North America laboratory accessories market is expected to witness significant growth over the forecast period. Presence of leading manufacturers, robust research and development activities, and continuous demand for lab accessories is expected to support global laboratory accessories market growth over the forecast period. For instance, manufacturers such as Thermo Fisher Scientific have high presence in North America, which provides innovative lab accessory solutions in the regional market.

Europe laboratory accessories market is also expected to witness significant growth over the forecast period due to rising disease prevalence and increasing research and development of drug therapies. According to World Health Organization (WHO), there is a considerable increase in the number of patients suffering from measles during the year 2016-2017 in Europe, which would in turn increase the number of disease diagnosis centers in the region. These factors are expected to support the global laboratory accessories market growth in the respective regions.


Request For Customization Of This Business Research Report :
https://www.coherentmarketinsights.com/insight/request-customization/2035

Key players of Global Laboratory Accessories Market:-

Key players operating in the global laboratory accessories market include Thermo Fisher Scientific, Tecan group, Becton, Dickinson and Company, Corning Incorporated, Bio-Rad Laboratories, Hamilton Company, Analytik Jena, Greiner Bi-one, and Brooks Automation.


Global Laboratory Accessories Market Taxonomy:-

Global laboratory accessories market is segmented on the basis of product type, end users, and region


By Product Type-

  • Instruments
    • Centrifuges
    • Colorimeters
    • Conductivity Instruments
    • Balances & Scale
    • Desiccators
    • Flowmeters
    • Autoclaves & Sterilization Products
    • Homogenizers
    • Incubators
    • Others
  • Glassware
  • Lab Tables
  • Consumables
  • Others

By End Users:-

  • Hospitals
  • Private Labs
  • Research Institutes
  • Pathology Centers

These products provide flexible, reliable, and accurate automation solutions for all kinds of applications such as automated storage of stacked microplates, quick filling of the microplates, and others. These also provide efficiency, saves time which in turn helps in maintaining the quality of products, increasing the production and reducing the operating costs. According to National Science Foundation (NSF), the expenditure on laboratory automation is expected to double between 2010 and 2017 that will eventually boost growth of global laboratory accessories market over the forecast period.

Moreover, demand for diagnosis of infectious disease is also rising owing to increasing prevalence of various infectious diseases. According to World Health Organization (WHO), an estimated 36.7 million people were suffering from HIV in 2016. There is also a considerable increase in number of funding agencies for research institutes from the previous years, such as Science and Technology Application for Rural Development (STARD) 2015 and Intensification of Research in Higher Priority Areas (IRHPA) 2016, among others. These funding’s are expected to boost the global laboratory accessories market growth over the forecast period as lab accessories would be required to run the laboratories.


About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:

Mr. Shah
Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: sales@coherentmarketinsights.com

Sinus Dilation Devices Market

Sinus Dilation Devices Market Analysis 2018 Report by Dynamics, Scope, Competitors

Global Sinus Dilation Devices Market are used to treat sinus problem and expand the sinus openings of nose to treat nasal problems. According to the American College of Physicians March 2016, data it is reported that every year 4.3 million people are diagnosed with sinusitis. Such a high number of sinus patients may influence the market growth globally.

Sinus Dilation Devices Market Research Report by Product (Sinus Stents, Balloon Dilation, Endoscope), Procedure (Hybrid Sinus Dilation), Patient Type (Pediatric, Adults), End-User (Hospitals, ENT Clinics, and Others)-Global Forecast till 2023

Global Sinus Dilation Devices Market was estimated USD 3,326 million in 2016 and expected to reach USD 5,778 million by 2023 at a CAGR of 8.1% from 2018 to 2023.

Inquire for Sample Copy of this Report https://www.marketresearchfuture.com/sample_request/6644

Sinus is also called as chronic rhinosinusitis, it is a condition in which cavities around nasal known as (sinuses) get inflamed and swollen for weeks. The people suffering from sinus may have symptoms such as nasal block, tenderness, swelling of the face, sore throat, nausea, fatigue or irritability, and pain in jaw and teeth.

Key Players

Some of the key players in the global sinus dilation devices market are Sklar Surgical Instruments (US), Accurate Surgical & Scientific Instruments (USA), Bausch & Lomb Incorporated (US), Entellus Medical Inc. (a subsidiary of Stryker) (US), Acclarent Inc. (a subsidiary of Johnson & Johnson) (US), Medtronic plc (Ireland), Smith & Nephew plc (UK), Intersect ENT Inc. (US), Olympus Corporation (Japan), Meril Life, Sciences Pvt. Ltd. (India), SinuSys Corporation (US), Jilin Coronado Medical Ltd. (China), and others.

Global Sinus Dilation Devices Market is segmented on the basis of product, procedure, by patient type and end-user.

The sinus dilation devices market, by product, is segmented into sinus stents, balloon dilation, endoscope, functional endoscopic sinus surgery (FESS) instruments set, and handheld instruments. The endoscope is sub-segmented into rhinoscopy and sinoscopy.

By procedure, the market is segmented into hybrid sinus dilation procedure, standalone sinus dilation procedures, and others.

On the basis of patient type, the market is segmented into pediatric and adults.

On the basis of end-user, the market is segmented into hospitals, ENT clinics, diagnostic centers, research centers, and others.

Browse Complete Premium Research Report https://www.marketresearchfuture.com/reports/sinus-dilation-devices-market-6644

Global Market Regional Insights

Americas leads in the market owing to the increasing prevalence of rising incidence of bacterial infection, increasing research & development in sinus dilation devices and growing healthcare expenditure.

Europe is the second largest sinus dilation devices market during the forecast period. The increase in the prevalence of chronic sinus and increasing expenditure for sinus treatment may support the market growth.

Asia-Pacific was estimated to be the fastest growing region for the global sinus dilation devices market in 2017.

Middle East and Africa holds the lowest share for sinus dilation devices market.

About Market Research Future:

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact:

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar, Pune

+1 646 845 9312

Email: sales@marketresearchfuture.com

Indian Conjugate Vaccine Market Detailed Analysis Report 2018-2023

Bharat Book Bureau Provides the Trending Market Research Report on “Indian Conjugate Vaccine Market” under Life Sciences category. The report offers a collection of superior market research, market analysis, competitive intelligence and industry reports.

Conjugate Vaccine is a type of vaccine that contains bacterial capsular polysaccharide, attached to a protein to enhance immunogenicity and protects against invasive diseases. India is one of the most prominent markets of conjugate vaccines.

India is expected to be the fastest growing market due to the government’s focus on research and development in the life sciences domain. By making Pneumococcal Conjugate Vaccine (PCV) available under the Universal immunization program (UIP), the government of India is ensuring equitable access to those who need them the most – the underprivileged and underserved. Hib is one of the leading causes of bacterial meningitis in India and a major cause of childhood pneumonia. The introduction of LPV in India is a significant milestone and a step forward towards accelerating child survival in India, and progress towards achieving national health goals and the Millennium Development Goal 4.

Request a free sample copy Conjugate Vaccine of Market Report @ https://www.bharatbook.com/MarketReports/Sample/Reports/1166495

Indian Conjugate Vaccine Market

Market Segmentation:

  • Based on disease indication, the market is segmented into pneumococcal, haemophilus influenza type b, diphtheria-tetanus-pertussis, meningococcal and others.
  • Based on end user, the market is segmented into paediatric and adult.

Key growth factors:

India is projected to be the fastest growing market for conjugate vaccines during the forecast period. Rapidly increasing population, rise in consumer awareness, growing disposable income and healthcare expenditure, modernization of healthcare infrastructure, and a growing medical tourism industry will drive the growth of the Indian market.

Threats and key players:

  • The India conjugate vaccine market is expected to have significantly high growth. Delayed introduction of conjugate vaccines is likely to hold back the conjugate vaccine market. Though the prevalence of chronic diseases is high, limited availability and accessibility of conjugate vaccines in remote areas can become a cause for concern. Complicated manufacturing can also be a major restraint for this market.
  • Major conjugate vaccine providers operating in the market are GlaxoSmithKline, Pfizer Inc., Merck, Novartis, Sanofi Pasteur, etc.

What’s covered in the report?

  1. Overview of the India conjugate vaccine market
  2. Market drivers and challenges in the India conjugate vaccine market
  3. Market trends in India conjugate vaccine market
  4. Historical, current and forecasted market size data for India based on disease indication (pneumococcal, haemophilus influenza type b, diphtheria-tetanus-pertussis, meningococcal conjugate vaccines) – by revenue and by volume
  5. Historical, current and forecasted market size data for India based on end user (paediatric and adult conjugate vaccines) – by revenue and by volume
  6. Analysis of the competitive landscape and profiles of major companies operating in the Indian market

Why buy?

  • Understand the demand for conjugate vaccines to determine the viability of the market
  • Develop strategies based on the drivers and trends for each of the segments
  • Evaluate the value chain to define the workflow and to get an idea of the current position where you are placed
  • Recognize the key competitors of this market and respond accordingly
  • Identify the initiatives and growth strategies taken up by the major companies and decide on the direction for further growth
  • Define the competitive positioning by comparing the products and services with the key players in the market

Please continue to read the complete report:
https://www.bharatbook.com/MarketReports/India-Conjugate-Vaccine-Market-2018-2023/1166495

About Company

Bharat Book Bureau, We are an Indian-based global information aggregator, boasting 27 years of expertise in delivering rich, valuable business information and analysis. Since 1989, we have been providing our services to a large number of clients across the globe, including those from the corporate, government, academic, and banking sectors. Our products/services include up-to-date forecasts, market research reports, company profiles, online databases, customised research reports, country reports, and newsletters.

Contact us at:
Bharat Book Bureau
Tel: +91 22 27810772 / 27810773
Email: poonam@bharatbook.com
Website: www.bharatbook.com

Follow us on : Twitter, Facebook, LinkedIn, Google Plus

Page 1 of 2

Powered by WordPress & Theme by Anders Norén